CME Group price target raised to $255 from $250 at Citi

Citi raised the firm’s price target on CME Group (CME) to $255 from $250 and keeps a Buy rating on the shares. The company reported an “exceptional quarter,” the analyst tells investors in a research note. The firm says that while the stock reaction was muted as expectations were high and there was no update on the capital return strategy, incremental color on the earnings call “were clear positives.” It continues to like CME’s risk/reward here.